vs
Side-by-side financial comparison of EQUITY BANCSHARES INC (EQBK) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.
PROCEPT BioRobotics Corp is the larger business by last-quarter revenue ($83.1M vs $63.5M, roughly 1.3× EQUITY BANCSHARES INC). EQUITY BANCSHARES INC runs the higher net margin — 34.8% vs -38.1%, a 72.8% gap on every dollar of revenue. On growth, EQUITY BANCSHARES INC posted the faster year-over-year revenue change (28.4% vs 20.2%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs 6.6%).
Prosperity Bancshares, Inc. is a bank holding company headquartered in Houston, Texas with operations in Texas and central Oklahoma. As of December 31, 2019, the company operated 285 branches: 65 in the Houston area, including The Woodlands, Texas; 30 in South Texas, including Corpus Christi, Texas and Victoria, Texas; 75 in the Dallas–Fort Worth metroplex; 22 in East Texas; 29 in Central Texas, including Austin, Texas and San Antonio; 34 in West Texas, including Lubbock, Texas, Midland–Odess...
PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.
EQBK vs PRCT — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $63.5M | $83.1M |
| Net Profit | $22.1M | $-31.6M |
| Gross Margin | — | 64.9% |
| Operating Margin | 41.7% | -4.1% |
| Net Margin | 34.8% | -38.1% |
| Revenue YoY | 28.4% | 20.2% |
| Net Profit YoY | 30.0% | -27.9% |
| EPS (diluted) | $1.07 | $-0.56 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $83.1M | ||
| Q4 25 | $63.5M | $76.4M | ||
| Q3 25 | $18.0M | $83.3M | ||
| Q2 25 | $58.4M | $79.2M | ||
| Q1 25 | $60.6M | $69.2M | ||
| Q4 24 | $58.3M | $68.2M | ||
| Q3 24 | $55.3M | $58.4M | ||
| Q2 24 | $55.4M | $53.4M |
| Q1 26 | — | $-31.6M | ||
| Q4 25 | $22.1M | $-29.8M | ||
| Q3 25 | $-29.7M | $-21.4M | ||
| Q2 25 | $15.3M | $-19.6M | ||
| Q1 25 | $15.0M | $-24.7M | ||
| Q4 24 | $17.0M | $-18.9M | ||
| Q3 24 | $19.9M | $-21.0M | ||
| Q2 24 | $11.7M | $-25.6M |
| Q1 26 | — | 64.9% | ||
| Q4 25 | — | 60.6% | ||
| Q3 25 | — | 64.8% | ||
| Q2 25 | — | 65.4% | ||
| Q1 25 | — | 63.9% | ||
| Q4 24 | — | 64.0% | ||
| Q3 24 | — | 63.2% | ||
| Q2 24 | — | 59.0% |
| Q1 26 | — | -4.1% | ||
| Q4 25 | 41.7% | -40.6% | ||
| Q3 25 | -207.2% | -27.8% | ||
| Q2 25 | 31.5% | -28.0% | ||
| Q1 25 | 31.1% | -39.7% | ||
| Q4 24 | 35.0% | -28.9% | ||
| Q3 24 | 43.1% | -38.4% | ||
| Q2 24 | 29.4% | -50.3% |
| Q1 26 | — | -38.1% | ||
| Q4 25 | 34.8% | -39.1% | ||
| Q3 25 | -164.7% | -25.7% | ||
| Q2 25 | 26.1% | -24.7% | ||
| Q1 25 | 24.8% | -35.8% | ||
| Q4 24 | 29.1% | -27.6% | ||
| Q3 24 | 35.9% | -35.9% | ||
| Q2 24 | 21.1% | -48.0% |
| Q1 26 | — | $-0.56 | ||
| Q4 25 | $1.07 | $-0.54 | ||
| Q3 25 | $-1.55 | $-0.38 | ||
| Q2 25 | $0.86 | $-0.35 | ||
| Q1 25 | $0.85 | $-0.45 | ||
| Q4 24 | $1.06 | $-0.34 | ||
| Q3 24 | $1.28 | $-0.40 | ||
| Q2 24 | $0.76 | $-0.50 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $245.6M |
| Total DebtLower is stronger | $443.2M | $51.7M |
| Stockholders' EquityBook value | $732.1M | $347.7M |
| Total Assets | $6.4B | $487.1M |
| Debt / EquityLower = less leverage | 0.61× | 0.15× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $245.6M | ||
| Q4 25 | — | $286.5M | ||
| Q3 25 | — | $294.3M | ||
| Q2 25 | — | $302.7M | ||
| Q1 25 | — | $316.2M | ||
| Q4 24 | — | $333.7M | ||
| Q3 24 | — | $196.8M | ||
| Q2 24 | — | $214.1M |
| Q1 26 | — | $51.7M | ||
| Q4 25 | $443.2M | $51.6M | ||
| Q3 25 | $486.9M | $51.6M | ||
| Q2 25 | $448.4M | $51.5M | ||
| Q1 25 | $376.9M | $51.5M | ||
| Q4 24 | $312.8M | $51.5M | ||
| Q3 24 | $437.5M | $51.4M | ||
| Q2 24 | $391.7M | $51.4M |
| Q1 26 | — | $347.7M | ||
| Q4 25 | $732.1M | $365.9M | ||
| Q3 25 | $711.9M | $380.3M | ||
| Q2 25 | $635.6M | $385.8M | ||
| Q1 25 | $617.3M | $389.2M | ||
| Q4 24 | $592.9M | $402.2M | ||
| Q3 24 | $504.0M | $241.2M | ||
| Q2 24 | $461.4M | $251.8M |
| Q1 26 | — | $487.1M | ||
| Q4 25 | $6.4B | $508.1M | ||
| Q3 25 | $6.4B | $511.5M | ||
| Q2 25 | $5.4B | $513.1M | ||
| Q1 25 | $5.4B | $519.4M | ||
| Q4 24 | $5.3B | $534.0M | ||
| Q3 24 | $5.4B | $374.1M | ||
| Q2 24 | $5.2B | $374.4M |
| Q1 26 | — | 0.15× | ||
| Q4 25 | 0.61× | 0.14× | ||
| Q3 25 | 0.68× | 0.14× | ||
| Q2 25 | 0.71× | 0.13× | ||
| Q1 25 | 0.61× | 0.13× | ||
| Q4 24 | 0.53× | 0.13× | ||
| Q3 24 | 0.87× | 0.21× | ||
| Q2 24 | 0.85× | 0.20× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $51.4M | — |
| Free Cash FlowOCF − Capex | $38.1M | — |
| FCF MarginFCF / Revenue | 60.0% | — |
| Capex IntensityCapex / Revenue | 20.9% | — |
| Cash ConversionOCF / Net Profit | 2.33× | — |
| TTM Free Cash FlowTrailing 4 quarters | $88.8M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $51.4M | $-10.3M | ||
| Q3 25 | $8.5M | $-6.6M | ||
| Q2 25 | $28.3M | $-15.0M | ||
| Q1 25 | $21.7M | $-17.0M | ||
| Q4 24 | $73.8M | $-32.4M | ||
| Q3 24 | $23.5M | $-18.8M | ||
| Q2 24 | $16.0M | $-15.7M |
| Q1 26 | — | — | ||
| Q4 25 | $38.1M | $-12.2M | ||
| Q3 25 | $4.5M | $-9.5M | ||
| Q2 25 | $26.0M | $-17.8M | ||
| Q1 25 | $20.2M | $-18.8M | ||
| Q4 24 | $65.4M | $-33.6M | ||
| Q3 24 | $19.7M | $-19.0M | ||
| Q2 24 | $15.2M | $-16.8M |
| Q1 26 | — | — | ||
| Q4 25 | 60.0% | -15.9% | ||
| Q3 25 | 24.7% | -11.4% | ||
| Q2 25 | 44.5% | -22.5% | ||
| Q1 25 | 33.3% | -27.2% | ||
| Q4 24 | 112.1% | -49.2% | ||
| Q3 24 | 35.6% | -32.6% | ||
| Q2 24 | 27.4% | -31.4% |
| Q1 26 | — | — | ||
| Q4 25 | 20.9% | 2.4% | ||
| Q3 25 | 22.3% | 3.4% | ||
| Q2 25 | 3.9% | 3.5% | ||
| Q1 25 | 2.4% | 2.7% | ||
| Q4 24 | 14.6% | 1.7% | ||
| Q3 24 | 6.8% | 0.4% | ||
| Q2 24 | 1.5% | 2.0% |
| Q1 26 | — | — | ||
| Q4 25 | 2.33× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 1.85× | — | ||
| Q1 25 | 1.44× | — | ||
| Q4 24 | 4.35× | — | ||
| Q3 24 | 1.18× | — | ||
| Q2 24 | 1.37× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
EQBK
Segment breakdown not available.
PRCT
| Handpieces and other consumables | $43.0M | 52% |
| System sales and rentals | $23.4M | 28% |
| Other | $11.1M | 13% |
| Service | $5.6M | 7% |
